| Willamette Foot Center Inc | |
|
4305 River Rd N, Keizer, OR 97303-5506 | |
| (503) 363-0763 | |
| (503) 363-8154 |
| Full Name | Willamette Foot Center Inc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 4305 River Rd N, Keizer, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730797762 | NPI | - | NPPES |
| 295456 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| Provider Name | Robert C Stevens |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1114927910 PECOS PAC ID: 1850425638 Enrollment ID: I20100816000546 |
News Archive
An advisory from two leading allergists, Robert Wood of the Johns Hopkins Children's Center and Scott Sicherer of Mt. Sinai Hospital in New York, urges clinicians to use caution when ordering allergy tests and to avoid making a diagnosis based solely on test results.
Biospace med announced today that it continues to penetrate the U.S. market with its FDA-cleared ‘EOS' x-ray imager—the world's first ultra-low-dose x-ray technology—recently adding new customers in the Midwest and Southeast regions of the United States. In addition, Professor Georges Charpak, inventor of the EOS technology, has received the ‘Centenary Medal' from the French Radiological Society (SFR), the esteemed organization's highest honor.
IDM Pharma, Inc. today announced follow-up results from the Phase 2 study of IDM-2101 showing that the product candidate was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in HLA-A2 positive patients with non-small cell lung cancer (NSCLC) who were treated with IDM-2101, compared to a parallel external control group of HLA-A2 negative non-treated patients.
Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study.
A first-of-its-kind test that detects HIV infection earlier than ever before in the United States; a molecular assay for identification of two common sexually transmitted diseases; and an enhanced integrated analyzer offering significant workflow improvements; are among the many new advances Abbott will highlight at this year's American Association for Clinical Chemistry Lab Expo which starts today in Anaheim.
› Verified 2 days ago
| Provider Name | John W Sessions |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1750817714 PECOS PAC ID: 0143590620 Enrollment ID: I20200819001316 |
News Archive
An advisory from two leading allergists, Robert Wood of the Johns Hopkins Children's Center and Scott Sicherer of Mt. Sinai Hospital in New York, urges clinicians to use caution when ordering allergy tests and to avoid making a diagnosis based solely on test results.
Biospace med announced today that it continues to penetrate the U.S. market with its FDA-cleared ‘EOS' x-ray imager—the world's first ultra-low-dose x-ray technology—recently adding new customers in the Midwest and Southeast regions of the United States. In addition, Professor Georges Charpak, inventor of the EOS technology, has received the ‘Centenary Medal' from the French Radiological Society (SFR), the esteemed organization's highest honor.
IDM Pharma, Inc. today announced follow-up results from the Phase 2 study of IDM-2101 showing that the product candidate was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in HLA-A2 positive patients with non-small cell lung cancer (NSCLC) who were treated with IDM-2101, compared to a parallel external control group of HLA-A2 negative non-treated patients.
Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study.
A first-of-its-kind test that detects HIV infection earlier than ever before in the United States; a molecular assay for identification of two common sexually transmitted diseases; and an enhanced integrated analyzer offering significant workflow improvements; are among the many new advances Abbott will highlight at this year's American Association for Clinical Chemistry Lab Expo which starts today in Anaheim.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Willamette Foot Center Inc 4305 River Rd N, Keizer, OR 97303-5506 Ph: (503) 363-0763 | Willamette Foot Center Inc 4305 River Rd N, Keizer, OR 97303-5506 Ph: (503) 363-0763 |
News Archive
An advisory from two leading allergists, Robert Wood of the Johns Hopkins Children's Center and Scott Sicherer of Mt. Sinai Hospital in New York, urges clinicians to use caution when ordering allergy tests and to avoid making a diagnosis based solely on test results.
Biospace med announced today that it continues to penetrate the U.S. market with its FDA-cleared ‘EOS' x-ray imager—the world's first ultra-low-dose x-ray technology—recently adding new customers in the Midwest and Southeast regions of the United States. In addition, Professor Georges Charpak, inventor of the EOS technology, has received the ‘Centenary Medal' from the French Radiological Society (SFR), the esteemed organization's highest honor.
IDM Pharma, Inc. today announced follow-up results from the Phase 2 study of IDM-2101 showing that the product candidate was well tolerated, induced broadly specific cytotoxic T lymphocyte (CTL) responses, and showed a positive survival trend in HLA-A2 positive patients with non-small cell lung cancer (NSCLC) who were treated with IDM-2101, compared to a parallel external control group of HLA-A2 negative non-treated patients.
Men with lower cholesterol are less likely than those with higher levels to develop high-grade prostate cancer - an aggressive form of the disease with a poorer prognosis, according to results of a Johns Hopkins collaborative study.
A first-of-its-kind test that detects HIV infection earlier than ever before in the United States; a molecular assay for identification of two common sexually transmitted diseases; and an enhanced integrated analyzer offering significant workflow improvements; are among the many new advances Abbott will highlight at this year's American Association for Clinical Chemistry Lab Expo which starts today in Anaheim.
› Verified 2 days ago
Robert Stevens, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4305 River Rd N, Keizer, OR 97303 Phone: 503-363-0763 Fax: 503-363-8154 | |
Dr. Earl Dean Mcnabb, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3625 River Rd N, #275, Keizer, OR 97303 Phone: 503-390-0959 Fax: 503-390-1184 | |
Pacific Nw Foot And Ankle Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3625 River Rd N Ste 275, Keizer, OR 97303 Phone: 503-390-0959 Fax: 877-878-1984 | |
John Sessions, D.P.M., PHD Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 4305 River Rd N, Keizer, OR 97303 Phone: 503-363-0763 Fax: 503-363-8154 | |
Dr. Debra Kaye Lynch, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 4905 River Road N, Keizer, OR 97303 Phone: 503-304-5030 Fax: 503-606-2944 |